A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft.

Thomson, K J; Peggs, K S; Blundell, E; Goldstone, A H; Linch, D C

Thomson, K J; Peggs, K S; Blundell, E; Goldstone, A H; Linch, D C.

Affiliation

Thomson KJ; Department of Haematology, University College Hospital, London, UK. kirsty.thomson@uclh.nhs.uk

Leuk Lymphoma ; 48(5): 881-4, 2007 May.

Article in En | MEDLINE | ID: mdl-17487730

Subject(s)

Hematopoietic Stem Cell Transplantation/methods; Hodgkin Disease/therapy; Transplantation, Autologous/methods; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carmustine/therapeutic use; Cytarabine/therapeutic use; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation/mortality; Hodgkin Disease/mortality; Humans; Male; Melphalan/therapeutic use; Podophyllotoxin/therapeutic use; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Transplantation Conditioning

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Transplantation, Autologous / Hodgkin Disease / Hematopoietic Stem Cell Transplantation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links